LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 283 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 6.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,854,000 | -9.2% | 25,000 | 0.0% | 5.35% | -55.8% |
| Q1 2019 | $3,143,000 | -18.5% | 25,000 | -50.0% | 12.11% | +188.2% |
| Q1 2015 | $3,856,000 | +44.9% | 50,000 | 0.0% | 4.20% | -13.6% |
| Q4 2014 | $2,661,000 | +13.2% | 50,000 | 0.0% | 4.86% | +114.5% |
| Q3 2014 | $2,350,000 | – | 50,000 | – | 2.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
| Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
| VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
| Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
| Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
| Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
| Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
| Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |